The CD44 molecule is known to display extensive size heterogeneity, which has been attributed both to alternative splicing and to differential glycosylation within the exracellular domain. Although the presence of several alternative exons has been partly inferred from cDNA sequencing, the precise intron-exon oration of the CD44 gene has not been described to date to our knowledge. In the present study we describe the structure of the human CD44 gene, which contains at least 19 exons s ning some 50 kiobases of DNA. We have identified 10 alternatively spliced exons within the extracellular domain, including 1 exon that has not been previously reported. In addition to the cluson or excusion of whole exons, more diversity is generated through the uztion of internal splice donor and acceptor sites within 2 of the individual exons. The variation previously reported for the cytoplasmic domain is shown to result from the alternative splicing of 2 exons. The genomic structure of CD44 reveals a remarkable degree of complexity, and we confirm the role of alternative splicing as the basis of the structural and functional diversity seen in the CD44 molecule.
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The human CD44 glycoprotein [Pgp-1 (1) , HCAM (2) , Hermes antigen (3), ECMR III (4)] has been proposed to function as a lymph node homing receptor on circulating lymphocytes. Expressed on a wide range of different tissues, the CD44 molecule also binds the extracellular matrix components hyaluronic acid (5), fibronectin (6) , and collagen (4) as well as the cytoskeletal protein ankyrin (7) . Several antibodies recognizing CD44 have been shown to induce lymphocyte activation (8, 9) and to inhibit lymphopoiesis (10) . In addition, CD44 can mediate both homotypic and heterotypic cell adhesion (11, 12) . The many functional roles of this molecule may relate to its considerable size heterogeneity, which cannot be accounted for simply by differences in glycosylation (5, 13, 14) .
Recently, we and others have isolated a number of different isoforms of CD44 (15) (16) (17) (18) . These have been characterized by cDNA sequencing and appear to arise by alternative splicing in two different regions, the membrane proximal extracellular domain and the cytoplasmic tail. Some of this variation has been shown to produce functional changes in the molecule. For example, the presence ofthe 396-base-pair (bp) insert in the epithelial variant of CD44 reduces the affinity for hyaluronic acid (5) . Study ofthese cDNA variants has given some insight into the genomic organization of CD44 but has not allowed the precise characterization of the number and boundaries of exons that encode the variant region of the molecule.
In the present paper we have cloned the gene for CD44 from a human yeast artificial chromosome (YAC) and characterized its genomic structure.* These studies reveal a remarkable degree of complexity within the structure of the CD44 gene and demonstrate conclusively the role of alternative splicing in generating the structural heterogeneity that is characteristic of the CD44 molecule.
MATERIALS AND METHODS
Isolatin, Chatization, and Sudoing of a CD44-Contining YAC. The primer pair Fil-Ril was used to screen a YAC library provided by the U.K. Human Genome Mapping Resource Centre (19) by the PCR method (20) . Total yeast DNA from positive YACs was prepared in agarose blocks (21) and analyzed by pulsed-field gel electrophoresis, Southern transfer, and hybridization to 32P-labeled CD44 cDNA variant E (17) . A partial restriction map was generated by the partial digestion and indirect end-labeling method (21) .
To obtain subclones of the YAC, total yeast DNA in agarose blocks from one of the YAC clones was digested for 2 min with 1 unit of Taq I per jig of DNA. After phenol/ chloroform extraction, the fragments were cloned into the unique Cla I site of pL53In (22) and used to transform Escherichia coli DH5a cells. Clones containing CD44 were identified by colony hybridization to 32P-labeled CD44 variant E (17) and intron PCR products (this paper). Plasmid DNA was prepared by standard methods (23) 
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RESULTS AND
Most of the introns, except those between exons 1 and 2, 3 and 4, 5 and 6, and 18 and 19, were readily amplified from genomic DNA; PCR products or subclones were sequenced to reveal the precise splice boundaries and the flanking splice sites. The coding sequence of the gene and intron sizes estimated from PCR are shown in Fig. 2 (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) including one, exon 6 , that has not been previously described (Fig. 3) . Nine of these variable-region exons (exons [6] [7] [8] [9] [10] [11] [12] [13] [14] can be skipped by alternative splicing, while exon 5 contains an alternative splice donor site; in addition, exon 7 contains two distinct splice acceptor sites. A variant has also been described in the rat, where the homologue of human exon 15 has been spliced out (25) , giving even greater potential diversity to this region.
Exon 6 was identified in cDNA from the colon carcinoma cell line HT-29 by PCR, where we designed primers to search for new exons by amplification between variable region exons that were presumed to be adjacent. Amplification between exons 5 and 7 consistently produced a product 320 bp long in addition to the expected product of 191 bp (Fig. 4) . The larger product was directly sequenced and shown to contain the 129-bp insert, exon 6 (Fig. 2) . The sequence of exon 6 encodes a 43-amino acid peptide that contains a high proportion of serine and threonine residues, a feature that is shared with the other alternative exons, allowing for extensive 0-linked glycosylation. This new exon was also detected in several other cDNAs including mammary and bladder tumors by PCR (data not shown). We have preliminary evidence for further alternatively spliced exons lying between exons 5 and 6 in the mouse (data not shown).
The cDNA sequences for this variable region can now be located on our new exon map (Fig. 3) ; exons 14, 13, 12, 7, and 11 correspond to exons 1-5 previously reported from our The dashed lines in C represent introns, the sizes of which can only be estimated from the restriction data and cannot be directly measured. (26); however, some of this sequence differs from that generated in our study. We could find no evidence of polymorphism to account for these differences after sequencing the region from nine different haplotypes from four individuals and the YAC clone.
CytoplasMic Tail. cDNA variants of CD44 that encode long (27) and short (2) Fig. 2 ). Open boxes represent constitutive exons, and solid boxes represent alternative exons that can be wholly spliced out. Alternative splice donor and acceptor sites on exons 5 (18). In the less abundant form, the DNA encoding the cytoplasmic tail is truncated to 9 bp and is followed by a distinct 3' UTR. As the junction between short and long tails contains the invariant part of the splice donor consensus GT in humans, baboons (28) , and mice (29), it has been proposed that the short tail is generated by splicing from an internal splice donor sequence within the long tail to a downstream 3' untranslated exon (30) . This is not the case; in fact characterization of the exons encoding the cytoplasmic tails reveals that the coding and 3' UTR of the long tail are both carried on exon 19, while exon 18 carries the 3' UTR associated with the short-tailed variant of CD44 and exon 17 carries the transmembrane domain and first three amino acids of the cytoplasmic tail, which are shared by both long-and shorttailed variants (Fig. 2) .
R R R R 6 7 8 9 R R R R R R 10 4 . Autoradiogram of PCR products generated by using cDNA from the colon cancer line HT-29 as template. A common primer F5 was used in all of the reactions along with exon-specific primers for the variable region exons, R6-R14. The product generated by the combination of F5 with R15 spans the whole of the insertion site in the membrane-proximal extracellular domain. Products were run on a 2% agarose gel and then transferred onto Hybond-N+ (Amersham). After transfer, the membrane was probed with the oligonucleotide R5, which lies internal to F5 in the backbone sequence of the molecule and will detect all CD44-containing products. The figure shows the two products generated with the primer pair F5-R7, the upper band contains exon 6 and also shows the diversity of transcripts produced by this cell line with more than one product in most of the lanes. A major band of 534 bp in the products generated by using the primer pair of F5-R15, which span the whole insertion site, corresponds to the epithelial variant of CD44, containing variable exons 12-14, while the lowest band of 148 bp represents the hemopoietic variant lacking exons [6] [7] [8] [9] [10] [11] [12] [13] [14] (Fig. 3) .
Concusions. With 12 of 19 exons being capable of alternative splicing and the common use of alternative donor or acceptor splice sites within exons, CD44 is potentially one of the most extensively alternatively spliced genes reported to date. Both the fibronectin gene (31) and CD45 (32) contain three alternatively spliced exons, whereas the rat a tropomyosin gene (33) and NCAM (34) can alternatively splice 10 of 15 exons and 12 of 27 exons, respectively. None of these examples contain a tandem array of at least 10 exons that appear to be selected at random as is the case with CD44, which gives enormous potential diversity. Tissue-specific patterns of alternative splicing have been shown to have important functional correlates in several systems including sex determination in Drosophila (35) and ligand specificity for fibronectin (31) . In CD44 the role of one alternatively spliced variant in enhancing the metastatic potential of rat tumors (25) indicates that the membrane proximal extracellular domain may have important effects in mediating cell adhesion and targeting. This is supported by the effect of the introduction of exons 12-14 in abrogating hyaluronic acid binding by the human epithelial variant (5) . The functional roles of many other splice variants of CD44 remain to be established.
The alternative splicing of the cytoplasmic tail may relate to the potential role ofthe CD44 molecule in T-cell activation. Alteration in the length of the cytoplasmic tail may modulate intracellular signaling, as the cytoplasmic tail has potential sites for the action of both protein kinases A and C (14) . Furthermore, it has been shown that CD44 associates with cytoskeletal actin filaments and ankyrin, presumably via the cytoplasmic tail. In macrophages activation increases CD44 phosphorylation and reduces contacts with the cytoskeleton (14) . In lymphocytes CD44 has been demonstrated to be associated with protein kinase C. Protein kinase C activation by anti-CD44 monoclonal antibodies may be involved in both ankyrin binding (36) and the promotion of T-cell adhesion via LFA-1 (lymphocyte function-association antigen 1) (11). In addition, variation in the length of the cytoplasmic tail may also affect the ability of the molecule to bind specific ligands through the N-terminal domain, as the short tail has been shown to reduce hyaluronic acid binding by the hemopoietic variant (37) . Interestingly the DNA sequence for the shorttail 3' UTR carries a long A+T-rich tract (Fig. 2) . Similar A+U-rich elements have been found in the 3' UTRs of several mRNAs coding for growth factors and protooncogenes and are implicated in targeting the mRNA for rapid turnover (38) .
The tissue-specific patterns ofCD44 alternative exon usage suggest that the regulation of splicing not only is responsible for the characteristic size heterogeneity but also may affect the function of the molecule. Although individual cell lines appear to express a number of different CD44 transcripts (Fig. 4) , it remains to be established whether single cells also express more than one isoform of CD44.
Comparison of splice donor and acceptor sites flanking the alternatively spliced exons has revealed no obvious variation from consensus sequences. However, analysis of the polypyrimidine tract from -14 to -4 bp before the splice acceptor site reveals a pyrimidine content of 87% for the constitutive exons (1-5 and 15-17) compared with 65% for the alternative exons (6-14, 18, and 19) . Increasing the pyrimidine content of this tract has been demonstrated to reverse exon skipping in artificial constructs (39) .
The genomic structure of CD44 presented here should facilitate the characterization of isoforms expressed in a number of different cell types including tumors and lymphocytes. In lymphocytes the regulated expression of CD44 isoforms may be involved in activation, targeting, and ontogeny, while in nonlymphoid tissues it may play an important role in the control of cell adhesion. Future studies on the nature and control of alternative splicing of CD44 together with functional studies of the alternatively spliced exons, particularly their ligand specifities, may help to shed further light onto these events.
